Celesio branches into contract sales
Celesio has bought a 30 per cent stake in Pharmexx, the number two contract sales organisation in Europe, in a bid to get a foothold in this market segment and diversify its business.
Archives for May 3, 2006
G-protein modification key to better drug efficacy
A new study holds much promise for a new approach to drug therapy after researchers have revealed details of a mechanism that actually modifies the effect of a major drug class.
Nabi bags Sanofi vaccines contract
US-based Nabi Biopharmaceuticals has secured an exclusive supply and contract manufacturing deal with French-based vaccines giant Sanofi Pasteur to streamline the production of its rabies vaccine.
PPD's PDL biomarker deal points to wider trend
PPD has announced it has signed an agreement with PDL BioPharma in which the contract research organisation is to perform comprehensive molecular profiling to discover biomarkers.
CyBio displays liquid handling kit at Analytica
CyBio presents its new liquid handling platform and pipetting system at Analytica in Munich, which aims to meet customer needs in drug discovery processes that require precision and accuracy when handling fluid materials.
Outsourcing-Pharma focus on: Phase IIIB-IV research
CROs to benefit from FDA's push to clear Phase IV backlog
The US Food & Drug Administration's (FDA) drive to clear the mounting backlog of post-marketing (Phase IV) drug trials signals good news for the clinical research organisations (CROs) who are poised to benefit.
Mice tests reveal scope for diabetes cure
Scientists believe they have made a major breakthrough in a potential cure for diabetes after animal experiments using a combinatorial treatment approach reversed onset type 1 diabetes.